# Providing Regulatory Submissions in Electronic Format: IND Safety Reports Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/providing-regulatory-submissions-in-electronic-format-ind-safety-reports-guidance-for-industry/d8a7e884-2739-4461-b12b-7feef9321c17

> FDA guidance document: Providing Regulatory Submissions in Electronic Format: IND Safety Reports Guidance for Industry. Issue date: April 01, 2024. Get complete insights and analysis.

---

## Details

- Title: Providing Regulatory Submissions in Electronic Format: IND Safety Reports Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2024-04-01
- Last Changed: 2024-04-01
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2019-D-3953">FDA-2019-D-3953</a>

## Related Documents

- [Bladder Cancer: Developing Drugs and Biologics for Adjuvant Treatment:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/bladder-cancer-developing-drugs-and-biologics-for-adjuvant-treatment-guidance-for-industry/b3fd959c-72c5-4e86-a4a9-5fa31d0ce7b7)
- [Renal Cell Carcinoma: Developing Drugs and Biologics for Adjuvant Treatment:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/renal-cell-carcinoma-developing-drugs-and-biologics-for-adjuvant-treatment-guidance-for-industry/db30c852-ed7b-4054-8906-3aadd3851179)
- [Cross Labeling Oncology Drugs in Combination Regimens](https://www.globalkeysolutions.net/guidances/guidance-document/cross-labeling-oncology-drugs-in-combination-regimens/d50f604f-4d0f-4aaa-a83a-b8a75b4a71ee)